Torrent Pharmaceuticals Ltd (IN:TORNTPHARM)
:TORNTPHARM
Want to see IN:TORNTPHARM full AI Analyst Report?
Total Valuation
Torrent Pharmaceuticals Ltd has a market cap or net worth of ₹1.50T. The enterprise value is ₹1.64T.
Market Cap₹1.50T
Enterprise Value₹1.64T
Share Statistics
Torrent Pharmaceuticals Ltd has 338,431,850 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding338,431,850
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Torrent Pharmaceuticals Ltd’s return on equity (ROE) is 0.26 and return on invested capital (ROIC) is 6.58%.
Return on Equity (ROE)0.26
Return on Assets (ROA)0.05
Return on Invested Capital (ROIC)6.58%
Return on Capital Employed (ROCE)0.10
Revenue Per Employee8.89M
Profits Per Employee1.38M
Employee Count15,718
Asset Turnover0.32
Inventory Turnover2.28
Valuation Ratios
The current PE Ratio of Torrent Pharmaceuticals Ltd is 69.5. Torrent Pharmaceuticals Ltd’s PEG ratio is 5.00.
PE Ratio69.5
PS Ratio10.22
PB Ratio17.02
Price to Fair Value17.02
Price to FCF73.05
Price to Operating Cash Flow144.74
PEG Ratio5.00
Income Statement
In the last 12 months, Torrent Pharmaceuticals Ltd had revenue of 139.80B and earned 21.63B in profits. Earnings per share was 63.92.
Revenue139.80B
Gross Profit68.24B
Operating Income34.62B
Pretax Income28.72B
Net Income21.63B
EBITDA32.57B
Earnings Per Share (EPS)63.92
Cash Flow
In the last 12 months, operating cash flow was 10.38B and capital expenditures -1.96B, giving a free cash flow of 8.42B billion.
Operating Cash Flow10.38B
Free Cash Flow8.42B
Free Cash Flow per Share24.88
Dividends & Yields
Torrent Pharmaceuticals Ltd pays an annual dividend of ₹9, resulting in a dividend yield of 0.84%
Dividend Per Share₹9
Dividend Yield0.84%
Payout Ratio49.73%
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.48
52-Week Price Change41.10%
50-Day Moving Average4.33K
200-Day Moving Average3.96K
Relative Strength Index (RSI)50.45
Average Volume (3m)7.49K
Important Dates
Torrent Pharmaceuticals Ltd upcoming earnings date is Jul 28, 2026, TBA (Confirmed).
Last Earnings DateMay 22, 2026
Next Earnings DateJul 28, 2026
Ex-Dividend Date―
Financial Position
Torrent Pharmaceuticals Ltd as a current ratio of 1.13, with Debt / Equity ratio of 179.10%
Current Ratio1.13
Quick Ratio0.75
Debt to Market Cap0.10
Net Debt to EBITDA4.27
Interest Coverage Ratio8.99
Taxes
In the past 12 months, Torrent Pharmaceuticals Ltd has paid 7.34B in taxes.
Income Tax7.34B
Effective Tax Rate0.26
Enterprise Valuation
Torrent Pharmaceuticals Ltd EV to EBITDA ratio is 48.11, with an EV/FCF ratio of 80.15.
EV to Sales11.21
EV to EBITDA48.11
EV to Free Cash Flow80.15
EV to Operating Cash Flow59.54
Balance Sheet
Torrent Pharmaceuticals Ltd has ₹10.33B in cash and marketable securities with ₹28.22B in debt, giving a net cash position of -₹17.89B billion.
Cash & Marketable Securities₹10.33B
Total Debt₹28.22B
Net Cash-₹17.89B
Net Cash Per Share-₹52.86
Tangible Book Value Per Share-₹321.20
Margins
Gross margin is 66.11%, with operating margin of 24.76%, and net profit margin of 15.47%.
Gross Margin66.11%
Operating Margin24.76%
Pretax Margin20.54%
Net Profit Margin15.47%
EBITDA Margin23.30%
EBIT Margin23.30%
Analyst Forecast
The average price target for Torrent Pharmaceuticals Ltd is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast21.40%
EPS Growth Forecast13.19%